Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Etsy, Maintains $160 Price Target By Benzinga Newsdesk Today, 11:12 AM Needham analyst Anna Andreeva reiterates Etsy (NASDAQ:ETSY) with a Buy and maintains $160 price target. ETSY
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Clene, Maintains $15 Price Target By Benzinga Newsdesk Today, 11:12 AM HC Wainwright & Co. analyst Joseph Pantginis reiterates Clene (NASDAQ:CLNN) with a Buy and maintains $15 price target. CLNN
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on PennantPark Floating Rate, Maintains $12 Price Target By Benzinga Newsdesk Today, 11:12 AM JMP Securities analyst Kevin Fitzsimmons reiterates PennantPark Floating Rate (NYSE:PFLT) with a Market Outperform and maintains $12 price target. PFLT
Read More 1 minute read Analyst Ratings News Price Target Reiteration Wedbush Reiterates Outperform on Cognizant Tech Solns, Maintains $75 Price Target By Benzinga Newsdesk Today, 11:12 AM Wedbush analyst Moshe Katri reiterates Cognizant Tech Solns (NASDAQ:CTSH) with a Outperform and maintains $75 price target. CTSH
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Marketwise, Maintains $6 Price Target By Benzinga Newsdesk Today, 11:12 AM JMP Securities analyst Devin Ryan reiterates Marketwise (NASDAQ:MKTW) with a Market Outperform and maintains $6 price target. MKTW
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on LPL Finl Hldgs, Maintains $290 Price Target By Benzinga Newsdesk Today, 11:12 AM JMP Securities analyst Devin Ryan reiterates LPL Finl Hldgs (NASDAQ:LPLA) with a Market Outperform and maintains $290 price target. LPLA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Mizuho Reiterates Neutral on ACADIA Pharmaceuticals, Maintains $19 Price Target By Benzinga Newsdesk Today, 11:12 AM Mizuho analyst Uy Ear reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and maintains $19 price target. ACAD
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Oatly Group, Maintains $7 Price Target By Benzinga Newsdesk Today, 11:12 AM RBC Capital analyst Nik Modi reiterates Oatly Group (NASDAQ:OTLY) with a Outperform and maintains $7 price target. OTLY
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Adobe, Maintains $395 Price Target By Benzinga Newsdesk Today, 11:12 AM RBC Capital analyst Matthew Hedberg reiterates Adobe (NASDAQ:ADBE) with a Outperform and maintains $395 price target. ADBE
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Sector Perform on UiPath, Maintains $15 Price Target By Benzinga Newsdesk Today, 11:12 AM RBC Capital analyst Matthew Hedberg reiterates UiPath (NYSE:PATH) with a Sector Perform and maintains $15 price target. PATH